Comparative PK/PD of Single-Dose THDB0206 at Different Injection Sites

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This open-label, randomized, three-period crossover, 8-hour hyperinsulinemic-euglycemic clamp study will compare the pharmacokinetic and pharmacodynamic profiles of THDB0206 after single subcutaneous administration at different injection sites in healthy Chinese adults.
Epistemonikos ID: e12a2c4f25bebff2079c96c652ba2aeb2f3b6cef
First added on: Dec 03, 2025